Skip to Content
Merck

F9677

Felodipine

L-type calcium channel blocker, solid

Synonym(s):

4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinecarboxylic acid ethyl methyl ester, Plendil

Sign In to View Organizational & Contract Pricing.

Select a Size



About This Item

Empirical Formula (Hill Notation):
C18H19NO4Cl2
CAS Number:
Molecular Weight:
384.25
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:

Product Name

Felodipine, solid

SMILES string

CCOC(=O)C1=C(C)NC(C)=C(C1c2cccc(Cl)c2Cl)C(=O)OC

InChI key

RZTAMFZIAATZDJ-UHFFFAOYSA-N

InChI

1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3

form

solid

solubility

DMSO: 20 mg/mL
H2O: insoluble

originator

AstraZeneca

Quality Level

Looking for similar products? Visit Product Comparison Guide

Biochem/physiol Actions

L-type calcium channel blocker

Features and Benefits

This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

General description

Felodipine is a dihydropyridine derivative. It has diuretic properties. Felodipine has high vascular selectivity. It is used to treat hypertension. Felodipine regulates chronic stable angina.

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Repr. 2 - STOT RE 2 Inhalation

Storage Class

11 - Combustible Solids

wgk

WGK 3

ppe

dust mask type N95 (US), Eyeshields, Gloves


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Meyler's Side Effects of Cardiovascular Drugs (2009)
Effects of felodipine on haemodynamics and exercise capacity in patients with angina pectoris.
Sheridan JV, et al.
British Journal of Clinical Pharmacology, 23(4), 391-396 (1987)
Sofia A Papadimitriou et al.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 82(1), 175-186 (2012-06-27)
In the present study, the efficiency of PVP/PEG200 mixtures as appropriate carries for the preparation of solid dispersions by melt mixing was evaluated. Felodipine (FELO) was used as a poorly water soluble model drug. The effect of several melt mixing
Sheng Qi et al.
Pharmaceutical research, 28(9), 2311-2326 (2011-05-25)
To characterise phase separations in aged hot-melt-extruded solid dispersions at a micron to submicron scale. Hot-melt-extruded felodipine and Eudragit® E PO systems at a range of compositions were studied after a standard period of aging to allow phase separation to
Nikolaos Scoutaris et al.
Journal of controlled release : official journal of the Controlled Release Society, 156(2), 179-185 (2011-08-11)
We demonstrate the viability of using an ink-jet printer to produce a formulation capable of controlling the release of a drug. This is shown for the drug felodipine, an antihypertensive, with polyvinyl pirrolidone (PVP) as an excipient. As felodipine is

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service